STERIS STE Healthcare Segment — Cost of Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by STERIS in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: STERIS’s 10-K, filed May 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about STERIS's healthcare segment — cost of revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is STERIS's healthcare segment — cost of revenue?
- STERIS (STE) reported healthcare segment — cost of revenue of $657.4M in Q1 2026.
- How has STERIS's healthcare segment — cost of revenue changed year-over-year?
- STERIS's healthcare segment — cost of revenue increased by 9.7% year-over-year, from $599.2M to $657.4M.
- What is the long-term trend for STERIS's healthcare segment — cost of revenue?
- Over 3 years (2023 to 2026), STERIS's healthcare segment — cost of revenue has grown at a 10.6% compound annual growth rate (CAGR), from $1.79B to $2.42B.
- What does healthcare segment — cost of revenue mean?
- This represents the direct costs attributable to the production and delivery of healthcare-related products and services, including raw materials, manufacturing labor, and direct overhead. Monitoring this metric is essential for assessing the segment's production efficiency and the impact of supply chain costs on gross margins.